Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Several adjuvant therapies have been attempted to reduce uni-centric, and intra- or
extrahepatic recurrence after curative surgical resection for hepatocellular carcinoma (HCC).
However, because the efficacy of such adjuvant therapy remains unclear, there is no standard
postoperative therapy.
The investigators investigated whether adjuvant hepatic arterial infusional chemotherapy with
5-fluorouracil (5-FU) and cisplatin reduces the recurrence of HCC after curative resection.